Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
CyD50 (functional) | < 1 ug ml-1 | Cytotoxic dose at which 50% growth of normal cells is inhibited against rhino virus infection. | ChEMBL. | 1847431 |
CyD50 (ADMET) | = 30 ug ml-1 | Cytotoxic dose at which 50% growth of normal cells is inhibited | ChEMBL. | 1847431 |
ED99 (functional) | > 30 ug ml-1 | Minimum drug concentration at which 99% of the polio virus is inhibited | ChEMBL. | 1847431 |
MNTD (functional) | = 30 ug ml-1 | Maximal non-toxic dose (MNTD) that shows antiviral activity. | ChEMBL. | 1847431 |
RF (functional) | = 10 | The ratio of the poliovirus viral titer of the virus control (reduction factor) to the viral titer in the presence of the maximal non-toxic dose (RF MNTD) | ChEMBL. | 1847431 |
TI 99 (functional) | < 1 | Therapeutic Index measured as the ratio of CyD50(polio) / ED99(polio) values | ChEMBL. | 1847431 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.